Details of the Drug Formulations

General Information of Drug (ID: DMC4GEI)

• Drug Name: Ospemifene Drug Info
• Synonyms: Ospemifene; 128607-22-7; Osphena; FC-1271a; Deamino-hydroxytoremifene; Fc-1271; 2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol; UNII-B0P231ILBK; CCRIS 9205; B0P231ILBK; CHEBI:73275; 2-(p-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol; senshio; Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-butenyl]phenoxy]-; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}ethanol; Ophena; Ospemifene [USAN:INN:BAN]; Deaminotoremifene; Osphena (TN); Deaminohydroxytoremifene; AC1MI19T; C24H23ClO2

Indication

Disease Entry	ICD 11	Status	REF
Dyspareunia	GA12	Approved	[1]
Postmenopausal vaginal atrophy	GA30.2	Phase 3	[1]

• Cross-matching ID:
  PubChem CID: 3036505
  ChEBI ID: CHEBI:73275
  CAS Number: 128607-22-7
  TTD ID: D02CTS
  INTEDE ID: DR1208
  ACDINA ID: D00496

Full List of Drug Formulations Containing This Drug

Ospemifene 60 mg tablet

Company	Formulation ID	FDA Description
Shionogi	F16073	Lactose monohydrate; Magnesium stearate; Mannitol; Titanium dioxide; Triacetin; Silicon dioxide; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified; Sodium starch glycolate type a potato; Starch, corn

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7349).